United States · FDA National Drug Code directory
BENZTROPINE MESYLATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-813_31bbcbfa-dc75-99e2-e063-6394a90aa608
- Product NDC
- 10135-813
- Form
- TABLET
- Composition / generic term
- benztropine mesylate
- Labeler
- Marlex PHARMACEUTICAL, INC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250301
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZTROPINE MESYLATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (10135-813-01) · 10135-813-01
- 1000 TABLET in 1 BOTTLE (10135-813-10) · 10135-813-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →